JLE

Hépato-Gastro & Oncologie Digestive

MENU

Proposals for the management of patients with liver disease on the occasion of the 2019 Coronavirus pandemic Volume 27, issue 5, Mai 2020

Figures

Authors
1 Hôpitaux Universitaires Paris Seine Saint-Denis, APHP ; Université Paris 13, Sorbonne Paris Cité ; INSERM UMR S-1138, Equipe FunGeST, Centre de recherche des Cordeliers
2 Hôpitaux Universitaires Paris Centre, APHP
3 Hôpital Edouard-Herriot, Hospices Civiles de Lyon ; Université Claude-Bernard Lyon 1
4 CHU Angers, Université d’Angers
5 CHU de Toulouse, Hôpital Purpan ; Université Paul Sabatier III, Toulouse
6 Hôpitaux Universitaires Henri Mondor APHP ; Université Paris Est, Créteil
7 Hôpital Saint Joseph, Marseille
* AFEF, Société Française d’Hépatologie
* Correspondant

This document, written by the French Association for the Study of the Liver (AFEF) board, aims to provide information to physicians involved in the care of patients with liver disease during the Coronavirus disease (COVID-19) epidemic. These are not based on a systematic review of the literature and a rigorous evaluation using the GRADE method. These are recommendations based on feedback from China available in the form of original articles or letters - for which the scientific evidence is often modest - and the rules put forward by American [1] and European [2] hepatology societies, the French National Digestive Cancer Thesaurus [3] and the Francophone Transplantation Society [4].

These suggestions require adjustment according to the geographical particularities of the epidemic, available standard procedures and access to local resources.

This document will be updated as regularly as possible according to the evolution of our knowledge and characteristics on the epidemic.